David Fishman

David Fishman

UNVERIFIED PROFILE

Are you David Fishman?   Register this Author

Register author
David Fishman

David Fishman

Publications by authors named "David Fishman"

Are you David Fishman?   Register this Author

99Publications

1211Reads

37Profile Views

Ruptured clear cell carcinoma of the ovary presenting as acute abdomen.

Gynecol Oncol Rep 2016 Apr 26;16:1-4. Epub 2016 Jan 26.

Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, Weill Cornell Medical College and New York Presbyterian/Queens Hospital, United States.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23525789163000
Publisher Site
http://dx.doi.org/10.1016/j.gore.2016.01.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899427PMC
April 2016

Complementary and alternative medicine therapies for the anesthesiologist and pain practitioner: a narrative review.

Can J Anaesth 2016 Jan 14;63(1):69-85. Epub 2015 Oct 14.

Veterans Affairs Medical Center, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12630-015-0506-9DOI Listing
January 2016

Postanesthesia Care for the Elderly Patient.

Clin Ther 2015 Dec 17;37(12):2651-65. Epub 2015 Nov 17.

US Department of Veterans Affairs, Atlanta VA Medical Center, Decatur, Georgia; Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2015.10.018DOI Listing
December 2015

microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition.

Nat Commun 2014 ;5:2977

1] Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, 1425 Madison Avenue, New York, New York 10029, USA [2] Case Comprehensive Cancer Center, Case Western Reserve University, 2103 Cornell Road, Cleveland, Ohio 44106, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms3977DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896774PMC
October 2015

Risk assessment for epithelial ovarian cancer: proposing a new approach to a deadly problem.

Scand J Clin Lab Invest Suppl 2014 ;244:63-7; discussion 66-7

Mount Sinai Medical Center, Department of Obstetrics, Gynecology and Reproductive Science , New York , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00365513.2014.936688DOI Listing
April 2015

Brain metastasis from uterine serous carcinoma: A case report and review of literature.

Gynecol Oncol Rep 2015 Jan 15;11:34-7. Epub 2015 Jan 15.

Department of Obstetrics, Gynecology & Reproductive Science, Icahn School of Medicine at Mount Sinai, 1176 Fifth Ave., Box 1170, New York, NY 10029, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2015.01.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434161PMC
January 2015

Expression of H1.5 and PLZF in granulosa cell tumors and normal ovarian tissues: a short report.

Cell Oncol (Dordr) 2014 Jun 15;37(3):229-34. Epub 2014 Jul 15.

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Science, Mount Sinai Medical Center, 1176 Fifth Avenue, 10029-6574, Box 1173, New York, NY, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13402-014-0174-8DOI Listing
June 2014

Survival analysis of robotic versus traditional laparoscopic surgical staging for endometrial cancer.

Am J Obstet Gynecol 2014 Feb 28;210(2):160.e1-160.e11. Epub 2013 Oct 28.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Abramson Cancer Center, Pennsylvania Hospital/University of Pennsylvania Health System, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2013.10.871DOI Listing
February 2014

Epithelial-mesenchymal transition enhances nanoscale actin filament dynamics of ovarian cancer cells.

J Phys Chem B 2013 Aug 26;117(31):9233-9240. Epub 2013 Jul 26.

Department of Biopharmaceutical Sciences, University of Illinois, Chicago, IL 60612.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jp4055186DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784653PMC
August 2013

Biomarkers for early detection of ovarian cancer.

Womens Health (Lond) 2013 Mar;9(2):171-85; quiz 186-7

Mount Sinai Medical Center, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/whe.13.2DOI Listing
March 2013

Does the type of surgery for early-stage endometrial cancer affect the rate of reported lymphovascular space invasion in final pathology specimens?

Am J Obstet Gynecol 2013 Jan 16;208(1):71.e1-6. Epub 2012 Oct 16.

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Science, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2012.10.009DOI Listing
January 2013

Early detection of ovarian cancer with conventional and contrast-enhanced transvaginal sonography: recent advances and potential improvements.

J Oncol 2012 26;2012:302858. Epub 2012 Apr 26.

Department of Radiology & Radiological Sciences, Vanderbilt University Medical Center, 37232 Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/302858DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351123PMC
August 2012

The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC).

Gynecol Oncol 2011 Oct 22;123(1):129-37. Epub 2011 Jul 22.

Department of Obstetrics, Gynecology and Reproductive Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2011.06.006DOI Listing
October 2011

Recognition of linear stress fibers based on Hough transform.

Anal Quant Cytol Histol 2011 Jun;33(3):121-31

Department of Pathology, Mount Sinai School of Medicine, New York, New York 10029, USA.

View Article

Download full-text PDF

Source
June 2011

MMP-1-PAR1 axis mediates LPA-induced epithelial ovarian cancer (EOC) invasion.

Gynecol Oncol 2011 Feb 20;120(2):247-55. Epub 2010 Nov 20.

Department of Obstetrics, Gynecology, and Reproductive Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258100077
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2010.10.032DOI Listing
February 2011

Soluble epidermal growth factor receptor: a biomarker of epithelial ovarian cancer.

Cancer Treat Res 2009 ;149:189-202

Division of Hematology, Oncology, Blood and Marrow Transplantation, Department of Internal Medicine, Lucille P. Markey Cancer Center, University of Kentucky, 408 Ben F. Roach Building, 800 Rose Street, Lexington, KY 40536-0093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-0-387-98094-2_9DOI Listing
September 2010

Lysophosphatidic acid and invasion.

Cancer Treat Res 2009 ;149:269-96

Department of Obstetrics Gynecology, and Reproductive Sciences, Mount Sinai School of Medicine, New York University, 1176 Fifth Avenue, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-0-387-98094-2_13
Publisher Site
http://dx.doi.org/10.1007/978-0-387-98094-2_13DOI Listing
September 2010

Biomarkers for ovarian cancer detection and therapy.

Cancer Biol Ther 2010 May 24;9(9):668-77. Epub 2010 May 24.

Department of Obstetrics, Gynecology and Reproductive Sciences, Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.9.9.11610DOI Listing
May 2010

Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity.

Gynecol Oncol 2010 Apr 6;117(1):88-95. Epub 2010 Jan 6.

Department of Obstetrics, Gynecology and Reproductive Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2009.12.012DOI Listing
April 2010

Advances in sonographic detection of ovarian cancer: depiction of tumor neovascularity with microbubbles.

AJR Am J Roentgenol 2010 Feb;194(2):343-8

Department of Radiology and Imaging Sciences, Vanderbilt University Medical Center, Nashville, TN 37232-2675, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.09.3446DOI Listing
February 2010

New frontiers for ovarian cancer risk evaluation: proteomics and contrast-enhanced ultrasound.

AJR Am J Roentgenol 2010 Feb;194(2):349-54

Department of Obstetrics, Gynecology, and Reproductive Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://www.ajronline.org/doi/10.2214/AJR.09.3763
Publisher Site
http://dx.doi.org/10.2214/AJR.09.3763DOI Listing
February 2010

VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion.

Gynecol Oncol 2009 Dec 18;115(3):414-23. Epub 2009 Sep 18.

Department of Obstetrics, Gynecology, and Reproductive Sciences, Mount Sinai School of Medicine, New York University, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2009.08.019DOI Listing
December 2009

Roles of LPA in ovarian cancer development and progression.

Future Oncol 2009 Dec;5(10):1659-73

Gynecologic Oncology, New York University School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.09.120DOI Listing
December 2009

Chemotherapy for gynecologic cancers.

Mt Sinai J Med 2009 Dec;76(6):577-88

Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/msj.20143DOI Listing
December 2009

Diagnostic parameters to differentiate benign from malignant ovarian masses with contrast-enhanced transvaginal sonography.

J Ultrasound Med 2009 Oct;28(10):1273-80

Department of Radiology, Vanderbilt University Medical Center, Nashville, TN 37232-2675, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7863/jum.2009.28.10.1273DOI Listing
October 2009

LPA receptor 2 mediates LPA-induced endometrial cancer invasion.

Gynecol Oncol 2009 Jan 18;112(1):215-23. Epub 2008 Nov 18.

Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2008.09.019DOI Listing
January 2009

The activity of medroxyprogesterone acetate, an androgenic ligand, in ovarian cancer cell invasion.

Reprod Sci 2008 Oct;15(8):846-52

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, New York University, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1933719108323446DOI Listing
October 2008

S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac.

Gynecol Oncol 2008 Aug 29;110(2):237-45. Epub 2008 May 29.

Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2008.04.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984540PMC
August 2008

Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: a role in ovarian pathogenesis.

Mol Oncol 2008 Aug 10;2(2):164-81. Epub 2008 May 10.

University of Texas, MD Anderson Cancer Center, Department of Systems Biology, 1515 Holcombe Boulevard, Box 950, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2008.05.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2598416PMC
August 2008

Contrast-enhanced transvaginal sonography of benign versus malignant ovarian masses: preliminary findings.

J Ultrasound Med 2008 Jul;27(7):1011-8; quiz 1019-21

Department of Radiology, Vanderbilt University Medical Center, RR-1213 MCN, 1161 21st Ave N, Nashville, TN 37232-2675, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7863/jum.2008.27.7.1011DOI Listing
July 2008

Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.

Cancer 2008 Apr;112(7):1489-502

Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23323DOI Listing
April 2008

Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner.

Gynecol Oncol 2008 Feb;108(2):361-9

Department of Obstetrics and Gynecology, New York University School of Medicine, 550 First Avenue, TH-528, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2007.10.027DOI Listing
February 2008

S1P and LPA have an attachment-dependent regulatory effect on invasion of epithelial ovarian cancer cells.

Gynecol Oncol 2007 Nov 22;107(2):298-309. Epub 2007 Aug 22.

Department of Obstetrics and Gynecology, New York University school of Medicine, 550 First Avenue, NB-9N28, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2007.06.024DOI Listing
November 2007

A robust biomarker discovery pipeline for high-performance mass spectrometry data.

J Bioinform Comput Biol 2007 Oct;5(5):1023-45

Division of Translational Research, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

View Article

Download full-text PDF

Source
October 2007

Conventional and proteomic technologies for the detection of early stage malignancies: markers for ovarian cancer.

Crit Rev Clin Lab Sci 2007 ;44(1):87-114

Department of Obstetrics and Gynecology, New York University School of Medicine, New York, New York 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10408360600778885 DOI Listing
April 2007

Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells.

Cancer Res 2007 Mar;67(5):2030-9

Departments of Cell and Molecular Biology and Pathology, Northwestern University Feinberg Medical School, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-2808DOI Listing
March 2007

The tumor microenvironment: key to early detection.

Crit Rev Clin Lab Sci 2006 ;43(5-6):393-425

Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10408360600778836 DOI Listing
February 2007

Ovarian cancer classification based on mass spectrometry analysis of sera.

Cancer Inform 2007 Feb 17;2:123-32. Epub 2007 Feb 17.

Department of Epidemiology and Public Health, Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2675484PMC
February 2007

Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells.

Mol Cancer Res 2007 Feb;5(2):121-31

Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-06-0319DOI Listing
February 2007

S1P regulation of ovarian carcinoma invasiveness.

Gynecol Oncol 2006 Dec 7;103(3):952-9. Epub 2006 Sep 7.

Department of Obstetrics and Gynecology, New York University School of Medicine, 550 First Avenue, NB-9N28, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2006.06.036DOI Listing
December 2006

Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion.

Mol Cancer Res 2006 Nov;4(11):831-41

Department of Obstetrics and Gynecology, New York University School of Medicine, 550 First Avenue, TH528, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-06-0153DOI Listing
November 2006

Progress in biomarker discovery for diagnostic testing in epithelial ovarian cancer.

Expert Rev Mol Diagn 2006 Jul;6(4):627-37

New York University School of Medicine, 550 First Avenue, TH538, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737159.6.4.627DOI Listing
July 2006

Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation.

Cancer Lett 2006 May 12;236(2):292-301. Epub 2005 Jul 12.

Department of Obstetrics and Gynecology, New York University School of Medicine, 550 First Avenue, NB-9N28, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2005.05.042DOI Listing
May 2006

Vascular endothelial growth factor-regulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinases.

Int J Cancer 2006 Feb;118(4):879-88

Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.21421DOI Listing
February 2006

Selective induction of cyclooxygenase-2 plays a role in lysophosphatidic acid regulated Fas ligand cell surface presentation.

FEBS Lett 2006 Jan 20;580(2):443-9. Epub 2005 Dec 20.

Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1016/j.febslet.2005.12.033
Publisher Site
http://dx.doi.org/10.1016/j.febslet.2005.12.033DOI Listing
January 2006

Analysis of albumin-associated peptides and proteins from ovarian cancer patients.

Clin Chem 2005 Oct 11;51(10):1933-45. Epub 2005 Aug 11.

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2005.052944DOI Listing
October 2005

Lysophosphatidic acid stimulates fas ligand microvesicle release from ovarian cancer cells.

Cancer Immunol Immunother 2005 Aug 21;54(8):807-14. Epub 2005 Jan 21.

Department of Immunology, University of Illinois at Chicago, Chicago 60612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-004-0642-5DOI Listing
August 2005

LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2).

Gynecol Oncol 2005 Jun;97(3):870-8

Department of Obstetrics and Gynecology, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2005.03.004DOI Listing
June 2005

Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.

J Clin Oncol 2005 May;23(15):3614-21

US Food and Drug Administration-National Cancer Institute Clinical Proteomics Program, Office of Cellular and Gene Therapy, Center for Biologics Evaluation and Research, FDA, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.02.509DOI Listing
May 2005

Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.

Mol Cell Proteomics 2005 Apr 25;4(4):346-55. Epub 2005 Jan 25.

United States Food and Drug Administration (FDA)-NCI Clinical Proteomics Program, Laboratory of Pathology, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://www.mcponline.org/lookup/doi/10.1074/mcp.T500003-MCP2
Publisher Site
http://dx.doi.org/10.1074/mcp.T500003-MCP200DOI Listing
April 2005

The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer.

Am J Obstet Gynecol 2005 Apr;192(4):1214-21; discussion 1221-2

Department of Obstetrics and Gynecology, New York University School of Medicine, 550 First Ave, NBV9N28, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2005.01.041DOI Listing
April 2005

Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase.

Int J Cancer 2005 Mar;114(1):19-31

Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.20697DOI Listing
March 2005

Estradiol-induced ezrin overexpression in ovarian cancer: a new signaling domain for estrogen.

Cancer Lett 2005 Mar;220(1):57-65

Department of Obstetrics and Gynecology, Yale University, P.O. Box 208063, 333 Cedar Street, FMB 331, New Haven, CT 06520-8063, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2004.04.024DOI Listing
March 2005

Translocation of Fas by LPA prevents ovarian cancer cells from anti-Fas-induced apoptosis.

Gynecol Oncol 2005 Feb;96(2):462-9

Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2004.10.024DOI Listing
February 2005

Lysophosphatidic acid inhibits anti-Fas-mediated apoptosis enhanced by actin depolymerization in epithelial ovarian cancer.

FEBS Lett 2005 Feb 26;579(5):1311-9. Epub 2005 Jan 26.

Department of Obstetrics and Gynecology, and R H Lurie Comprehensive Cancer Center, Northwestern University Medical School, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.febslet.2005.01.026DOI Listing
February 2005

Importance of communication between producers and consumers of publicly available experimental data.

J Natl Cancer Inst 2005 Feb;97(4):310-4

FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dji053DOI Listing
February 2005

Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.

Cancer Epidemiol Biomarkers Prev 2005 Feb;14(2):306-18

Department of Internal Medicine, Division of Hematology/Oncology, Lucille P. Markey Cancer Center, University of Kentucky, 408 Roach Building, 800 Rose Street, Lexington, KY 40536-0093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-04-0423DOI Listing
February 2005

Upregulation of FasL by LPA on ovarian cancer cell surface leads to apoptosis of activated lymphocytes.

Gynecol Oncol 2004 Dec;95(3):488-95

Department of Obstetrics and Gynecology, Northwestern University Medical School, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2004.07.052DOI Listing
December 2004

Telomerase prolongs the lifespan of normal human ovarian surface epithelial cells without inducing neoplastic phenotype.

J Soc Gynecol Investig 2004 Dec;11(8):553-61

Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1016/j.jsgi.2004.06.006
Publisher Site
http://dx.doi.org/10.1016/j.jsgi.2004.06.006DOI Listing
December 2004

Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8.

Gynecol Oncol 2004 Nov;95(2):314-22

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, New York University School of Medicine, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2004.08.001DOI Listing
November 2004

The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers.

Nat Med 2004 Nov 24;10(11):1251-6. Epub 2004 Oct 24.

Department of Molecular Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm1125DOI Listing
November 2004

Proinvasive properties of ovarian cancer ascites-derived membrane vesicles.

Cancer Res 2004 Oct;64(19):7045-9

Department of Cellular and Molecular Biology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-1800DOI Listing
October 2004

Lessons from Kitty Hawk: from feasibility to routine clinical use for the field of proteomic pattern diagnostics.

Proteomics 2004 Aug;4(8):2357-60

FDA-NCI Clinical Proteomics Program, Office of Cell and Gene Therapies, CBER, FDA, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pmic.200400865DOI Listing
August 2004

Clinical proteomics and biomarker discovery.

Ann N Y Acad Sci 2004 Jun;1022:295-305

NCI-FDA Clinical Proteomics Program, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1196/annals.1318.045DOI Listing
June 2004

A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physicians.

Gynecol Oncol 2004 Apr;93(1):164-9

Obstetrics and Gynecology-Gynecologic Oncology, Northwestern University Medical School, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2004.01.017DOI Listing
April 2004

Uterine leiomyosarcoma metastatic to the sphenoid sinus: a case report and review of the literature.

Gynecol Oncol 2004 Feb;92(2):701-4

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Prentice Women's Hospital, Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2003.10.043DOI Listing
February 2004

Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy.

Gynecol Oncol 2003 Dec;91(3):552-7

John I. Brewer Trophoblastic Disease Center, Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, 333 E. Superior Street, Suite 420, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2003.08.028DOI Listing
December 2003

Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays.

Proteomics 2003 Nov;3(11):2085-90

Center for Cancer Research, National Cancer Institute/NIH, Building 29A/Room 2B20, 8000 Rockville Pike, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pmic.200300591DOI Listing
November 2003

Genetic risk assessment for breast and ovarian cancer.

Adv Nurse Pract 2003 Oct;11(10):40-8

National Ovarian Cancer Early Detection Program, Northwestern Memorial Hospital, Chicago, USA.

View Article

Download full-text PDF

Source
October 2003

Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data.

Bioinformatics 2003 Sep;19(13):1636-43

Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/btg210DOI Listing
September 2003

General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer.

Gynecol Oncol 2003 Jan;88(1 Pt 2):S25-8; discussion S37-42

Laboratory of Pathology, National Cancer Institute, National Institutes of Health, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1006/gyno.2002.6679DOI Listing
January 2003

Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women.

Clin Cancer Res 2002 Nov;8(11):3324-31

Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas 75930, USA.

View Article

Download full-text PDF

Source
November 2002

Syphilis: have we dropped the ball?

CMAJ 2002 Nov;167(11):1267-8

CMAJ.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC134140PMC
November 2002

Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility.

Cancer Res 2002 Sep;62(18):5358-64

Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
September 2002

Localization of the activin signal transduction components in normal human ovarian follicles: implications for autocrine and paracrine signaling in the ovary.

J Clin Endocrinol Metab 2002 Jun;87(6):2644-57

Department of Neurobiology and Physiology, Northwestern University, 2153 North Campus Drive, Evanston, IL 60208, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jcem.87.6.8519DOI Listing
June 2002

Ultrasound and ovarian cancer.

Cancer Treat Res 2002 ;107:119-32

Department of Obstetrics and Gynecology, Divisions of Ultrasound and Gynecologic Oncology, Northwestern University Medical School, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4757-3587-1_5DOI Listing
April 2002

The scientific basis of early detection of epithelial ovarian cancer: the National Ovarian Cancer Early Detection Program (NOCEDP).

Cancer Treat Res 2002 ;107:3-28

Section of Gynecologic Oncology, Department of Obstetrics & Gynecology, Northwestern University Medical School, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4757-3587-1_1DOI Listing
April 2002

Early detection of ovarian cancer: promise and reality.

Cancer Treat Res 2002 ;107:61-97

Departments of Experimental Therapeutics, Molecular Therapeutics, Gynecologic Oncology and Anatomic Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4757-3587-1_3DOI Listing
April 2002

Use of proteomic patterns in serum to identify ovarian cancer.

Lancet 2002 Feb;359(9306):572-7

Food and Drug Administration/National Institutes of Health Clinical Proteomics Program, Department of Therapeutic Proteins/Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(02)07746-2DOI Listing
February 2002